论文信息 - Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial - 字舞流文

Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial

D. Hose | H. Goldschmidt | A. Jauch | A. Benner | A. Elmaagacli | P. Brossart | M. Merz | A. Seckinger | C. Scheid | S. Luntz | M. Munder | U. Bertsch | H. Salwender | M. Raab | E. Mai | K. Weisel | M. Haenel | I. Blau | S. Fuhrmann | H. Lindemann | J. Duerig | C. Jehn | B. Besemer | K. Miah